Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3 Randomized, Open-label Study Of Op-1250 Monotherapy Vs Standard Of Care For The Treatment Of Er+, Her2- Advanced Or Metastatic Breast Cancer Following Endocrine And Cdk 4/6 Inhibitor Therapy
Sponsored by PPD Development, LLC
Active
$512.6K Funding
2 People
External
Related Topics
breast cancer,
cancer treatment,
monotherapy,
endocrine therapy
People
Octavio Castanos
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Lizeth Evangelista
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
